CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for TAISHO PHARMACEUTICAL HOLDINGS Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

TAISHO PHARMACEUTICAL HOLDINGS Co Ltd
3-24-1, Takada
Phone: +81 339852020p:+81 339852020 TOSHIMA-KU, TKY  170-8655  Japan
This company is no longer actively traded on any major stock exchange.
Business Summary
Taisho Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products, and ethical drugs. The Company operates in two business segments. The Self-Medication segment is engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of ethical drugs. The other business is engaged in the leasing and management of real estate, as well as hotel management business.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research
7011 Hotels and motels
6512 Operators of nonresidential buildings
6531 Real estate agents and managers
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Chairman of Subsidiary, Representative Director AkiraUehara 81 6/1/2015 10/3/2011
CEO & President of Subsidiary, Director OsamuKitatani 64 6/1/2021 4/1/2015
Vice President, CEO & President of Subsidiary, Director ShigeruUehara 47 6/1/2015 6/1/2012
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
TAISHO PHARMACEUTICAL CO., LTD. 3-24-1, Takada, Toshima-ku Tokyo Japan
Biofermin Pharmaceutical Co Ltd 5-5, Samban-cho, Nagata-ku KOBE-SHI HYG Japan

Business Names
Business Name
Biofermin Pharmaceutical Co., Ltd.
Hoepharma Holdings Sdn. Bhd.
Mejiro Real Estate Co., Ltd.
17 additional Business Names available in full report.

General Information
Number of Employees: 8,784 (As of 3/31/2023)
Outstanding Shares: 81,967,464 (As of 12/31/2023)
Shareholders: 27,410
Stock Exchange: TYO


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 1, 2024